245 related articles for article (PubMed ID: 20496015)
1. MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis.
Penna G; Allegra A; Alonci A; Aguennouz M; Garufi A; Cannavò A; Gerace D; Alibrandi A; Musolino C
Med Oncol; 2011 Dec; 28(4):1549-54. PubMed ID: 20496015
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population.
Dong HJ; Miao KR; Qiao C; Zhuang Y; Shen WY; Hong M; Fan L; Liu P; Xu W; Li JY
Leuk Lymphoma; 2011 Jun; 52(6):1003-9. PubMed ID: 21463115
[TBL] [Abstract][Full Text] [Related]
3. MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia.
Jamroziak K; Balcerczak E; Smolewski P; Robey RW; Cebula B; Panczyk M; Kowalczyk M; Szmigielska-Kapłon A; Mirowski M; Bates SE; Robak T
Pharmacol Rep; 2006; 58(5):720-8. PubMed ID: 17085864
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between genetic polymorphism of multidrug resistance 1 gene and the risk of childhood acute lymphocytic leukemia].
Lü H; Du ZZ; Wang W; Wang W; Zhao WL; Wang Y; Hu SY; Chai YH
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):692-6. PubMed ID: 23158821
[TBL] [Abstract][Full Text] [Related]
5. MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia.
Matthews C; Catherwood MA; Larkin AM; Clynes M; Morris TC; Alexander HD
Leuk Lymphoma; 2006 Nov; 47(11):2308-13. PubMed ID: 17107902
[TBL] [Abstract][Full Text] [Related]
6. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
[TBL] [Abstract][Full Text] [Related]
7. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
[TBL] [Abstract][Full Text] [Related]
8. The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children.
Seven M; Batar B; Unal S; Yesil G; Yuksel A; Guven M
Mol Biol Rep; 2014 Jan; 41(1):331-6. PubMed ID: 24213830
[TBL] [Abstract][Full Text] [Related]
9. Association of C3435T, C1236T and C4125A Polymorphisms of the MDR-1 Gene in Egyptian Children with Acute Lymphoblastic Leukaemia.
Talaat RM; Y K El-Kelliny M; El-Akhras BA; Bakry RM; Riad KF; Guirgis AA
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2535-2543. PubMed ID: 30256048
[TBL] [Abstract][Full Text] [Related]
10. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
[TBL] [Abstract][Full Text] [Related]
11. The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.
Chen L; Li J; Zheng W; Zhang Y; Wu Y; Li L; Qian S; Xu W
Leuk Lymphoma; 2007 Sep; 48(9):1785-92. PubMed ID: 17786715
[TBL] [Abstract][Full Text] [Related]
12. Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-chronic lymphocytic leukemia.
Gangemi S; Allegra A; Aguennouz M; Alonci A; Speciale A; Cannavò A; Cristani M; Russo S; Spatari G; Alibrandi A; Musolino C
Cancer Invest; 2012 Jan; 30(1):20-6. PubMed ID: 22236186
[TBL] [Abstract][Full Text] [Related]
13. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
[TBL] [Abstract][Full Text] [Related]
14. ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia.
Trojani A; Montillo M; Nichelatti M; Tedeschi A; Colombo C; Veronese S; Mura MA; Ricci F; Scarpati B; Colosimo A; Lodola M; Morra E
Cancer Biomark; 2010; 6(1):1-9. PubMed ID: 20164537
[TBL] [Abstract][Full Text] [Related]
15. Variant genotypes of MDR1 C3435T increase the risk of leukemia: evidence from 10 case-control studies.
Qian X; Cao S; Yang G; Dong J; Jin G; Shen Y; Hu Z
Leuk Lymphoma; 2012 Jun; 53(6):1183-7. PubMed ID: 22088099
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of molecular and flow cytometric markers in chronic lymphocytic leukaemia.
Sulda ML; Kuss BJ; Hall RK; Bailey S; Macardle PJ
Intern Med J; 2012 Feb; 42(2):137-46. PubMed ID: 20561095
[TBL] [Abstract][Full Text] [Related]
17. MDR1 polymorphisms associated with risk and survival in diffuse large B-cell lymphoma.
Hu LL; Yu B; Yang J
Leuk Lymphoma; 2013 Jun; 54(6):1188-93. PubMed ID: 23088763
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
19. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
20. Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes.
Wu H; Kang H; Liu Y; Tong W; Liu D; Yang X; Lian M; Yao W; Zhao H; Huang D; Sha X; Wang E; Wei M
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1449-62. PubMed ID: 22526155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]